SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $16,160,000 | -13.3% | 460,520 | +11.6% | 0.03% | -15.2% |
| Q4 2015 | $18,641,000 | +2991.4% | 412,586 | +2535.8% | 0.03% | +3200.0% |
| Q3 2015 | $603,000 | -46.2% | 15,653 | -32.4% | 0.00% | -50.0% |
| Q2 2015 | $1,120,000 | +114.1% | 23,158 | +56.4% | 0.00% | +100.0% |
| Q1 2015 | $523,000 | -51.8% | 14,807 | -55.9% | 0.00% | -50.0% |
| Q4 2014 | $1,084,000 | +85.0% | 33,560 | +112.9% | 0.00% | +100.0% |
| Q3 2014 | $586,000 | +6.9% | 15,760 | +0.7% | 0.00% | 0.0% |
| Q2 2014 | $548,000 | +181.0% | 15,653 | +206.4% | 0.00% | – |
| Q1 2014 | $195,000 | +6.6% | 5,109 | +12.2% | 0.00% | – |
| Q4 2013 | $183,000 | -79.8% | 4,553 | -77.9% | 0.00% | -100.0% |
| Q3 2013 | $905,000 | +50.1% | 20,628 | +7.6% | 0.00% | +100.0% |
| Q2 2013 | $603,000 | – | 19,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |